Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
10/25/2024
Everest Medicines Launches VELSIPITY(R) in the Guangdong-HK-Macau Grea...
10/25/2024
CDE Solicits Comments on the Technical Guidelines for Clinical Researc...
10/25/2024
China and Denmark Strengthen Collaboration in Pharmaceutical and Medic...
10/24/2024
China's Innovative Drug Industry Faces Pricing Pressures Amid Steady D...
10/24/2024
CASI Granted Chinese CTA Approval for CID-103 in Immune Thrombocytope...
10/24/2024
Beijing Biostar Advances Lead Oncology Asset with $41M Hong Kong IPO
10/24/2024
Rouse: China's Rapid Rise in Global Innovation Strengthens Patent Syst...
10/24/2024
NHSA to Initiate New Round of Negotiation for 2024 NRDL Listing
10/24/2024
CDE Issues the Dossier Requirements for Marketing Registration Applica...
10/24/2024
CDE Solicits Comments on the Technical Guidelines for Evaluating pH-De...
10/24/2024
CDE Issues the Notice on Prioritized Acceptance Service for Innovative...
10/24/2024
Sinopharm and Chinese Vaccine Makers Slash Prices Amid Fierce Market C...
10/24/2024
Wuhan Hongchen Bio Secures CNY Tens of Mlns in Angel Round Financing, ...
10/24/2024
Legend Biotech Abandons Genscript as Majority Shareholder Amid Geopoli...
10/24/2024
Hengrui Pharma Considering Second Listing in Hong Kong
10/24/2024
Eccogene Receives $60M ilestone Payment from AstraZeneca Following Do...
10/24/2024
Hope Medicine Announces Positive Results from a Global Phase 2 Study o...
10/23/2024
China Recovers CNY 16B in Misused BMI Funds
10/23/2024
Guangzhou Aims to Establish Itself as a Global Biopharmaceutical Hub
10/22/2024
ArkBio's Ziresovir Set to Transform RSV Treatment in China
10/22/2024
Takeda: China to Emerge as Its Second-Largest Market by 2031
10/22/2024
XellSmart RaisesCNY 100M+ in Series B1 Financing for iPS-Derived Cell ...
10/22/2024
siRNA Developer Rigerna Secures CNY100M+ in Series Angel+ Funding
10/22/2024
Bristol Ends LaNova Partnership on Claudin18.2 ADC, Eyes Potential I-M...
10/22/2024
Oricell's IND for MSLN/Claudin 18.2 Dual CAR-T Therapy Cleared in Chin...
10/22/2024
Everest Announces Positive Results of Chinese Subpopulation Data from ...
10/22/2024
CDE Issues the Technical Requirements for the Pharmaceutical Research ...
10/21/2024
NMPA Issues the Pilot Plan for Staged Production of Biological Product...
10/21/2024
Europe's Share of Global Clinical Trials Shrinks as China Gains Ground...
10/21/2024
USFDA Grants Fast Track Designation to Coherent Biopharma's CBP-1008
Page:
14
/
42
Total number of articles:
1234
:
[First]
[<<]
[12]
[13]
[14]
[15]
[16]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit